BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8412322)

  • 21. Effects of treatment with cobra venom factor on experimentally induced feline leukemia.
    Kraut EH; Rojko JL; Olsen RG; Tuomari DL
    Am J Vet Res; 1987 Jul; 48(7):1063-6. PubMed ID: 2820273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental studies on membranous nephropathy. (II) Role of complement system in proteinuria of passive Heymann nephritis.
    Nishi T; Nosaka K; Kawasaki H
    Nihon Jinzo Gakkai Shi; 1984 Mar; 26(3):301-7. PubMed ID: 6748340
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic of respiratory manifestations at the early phase of acute myeloid leukaemia].
    Vincent F; Hospital MA; Lemiale V; Bruneel F; Darmon M; Gonzalez F; Kouatchet A; Mokart D; Pène F; Rabbat A; Cohen Y; Azoulay E;
    Rev Mal Respir; 2012 Jun; 29(6):743-55. PubMed ID: 22742462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of endogenous complement in monoclonal IgM antibody-dependent leukemia suppression in vivo: participation of C3b.
    Johnson RJ; Kaizer H; Massey AG; Shin HS
    J Immunol; 1985 May; 134(5):3497-503. PubMed ID: 3980999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of complement depletion on pulmonary dysfunction in porcine septic acute respiratory failure.
    Dehring DJ; Steinberg SM; Martin DT; Carey LC; Lowery BD; Cloutier CT
    Curr Surg; 1984; 41(3):195-7. PubMed ID: 6611244
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of bleomycin-induced pulmonary fibrosis by cobra venom factor.
    Phan SH; Thrall RS
    Am J Pathol; 1982 Apr; 107(1):25-8. PubMed ID: 6175222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of complement in Ascaris suum induced histopathology.
    Leventhal R; Bonner H; Soulsby EJ; Schreiber AD
    Clin Exp Immunol; 1978 Apr; 32(1):69-76. PubMed ID: 668193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic complement activation, lung injury, and products of lipid peroxidation.
    Ward PA; Till GO; Hatherill JR; Annesley TM; Kunkel RG
    J Clin Invest; 1985 Aug; 76(2):517-27. PubMed ID: 4031060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipopolysaccharide-induced pulmonary vascular sequestration of polymorphonuclear leukocytes is complement independent.
    Cardozo C; Edelman J; Jagirdar J; Lesser M
    Am Rev Respir Dis; 1991 Jul; 144(1):173-8. PubMed ID: 2064126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of complement and leukocytes in severe acute pancreatitis: potential for therapeutic intervention.
    Hartwig W; Klafs M; Kirschfink M; Hackert T; Schneider L; Gebhard MM; Büchler MW; Werner J
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G844-50. PubMed ID: 17030899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged cardiac allograft survival in presensitized rats after a high activity Yunnan-cobra venom factor therapy.
    Li R; Chen G; Guo H; Wang DW; Xie L; Wang SS; Wang WY; Xiong YL; Chen S
    Transplant Proc; 2006 Dec; 38(10):3263-5. PubMed ID: 17175243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of two types of cobra venom factor on porcine complement activation and pulmonary artery pressure.
    Cheung AK; Parker CJ; Wilcox L
    Clin Exp Immunol; 1989 Nov; 78(2):299-306. PubMed ID: 12412765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of decomplementation with cobra venom factor on experimental vasculitis.
    Mathieson PW; Qasim FJ; Thiru S; Oldroyd RG; Oliveira DB
    Clin Exp Immunol; 1994 Sep; 97(3):474-7. PubMed ID: 8082302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspiration-induced lung injury: role of complement.
    Rabinovici R; Neville LF; Abdullah F; Phillip DR; Vernick J; Fong KL; Hillegas L; Feuerstein G
    Crit Care Med; 1995 Aug; 23(8):1405-11. PubMed ID: 7634812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected infant death secondary to a pulmonary infiltration due to acute myelocytic leukaemia.
    Ben Khelil M; Chkirbene Y; Mlika M; Haouet S; Hamdoun M
    Malays J Pathol; 2017 Aug; 39(2):193-196. PubMed ID: 28866704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro resistance of the brown Norway rat acute myelocytic leukemia (BNML) to lymphokine-activated killer activity.
    Gaiser JF; Kloosterman TC; Martens AC; Hagenbeek A
    Leukemia; 1993 May; 7(5):736-41. PubMed ID: 8483327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echinococcus granulosus: interactions with host complement in secondary infection in mice.
    Díaz A; Ferreira AM; Nieto A
    Exp Parasitol; 1995 May; 80(3):473-82. PubMed ID: 7729482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid leukemias and lung involvement.
    Koh TT; Colby TV; Müller NL
    Semin Respir Crit Care Med; 2005 Oct; 26(5):514-9. PubMed ID: 16267702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation is a secondary rather than a causative factor in rabbit pulmonary artery ischemia/reperfusion injury.
    Bishop MJ; Giclas PC; Guidotti SM; Su ML; Chi EY
    Am Rev Respir Dis; 1991 Feb; 143(2):386-90. PubMed ID: 1990958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of decomplementation on mercuric chloride-induced glomerulonephritis in Brown-Norway rats.
    Capron M; Bascou C; Vial MC; Grossetete J; Hinglais N; Girard JF; Druet P
    Clin Exp Immunol; 1982 Sep; 49(3):611-7. PubMed ID: 6216993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.